At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and scientific fact-checking for the global public.

Given the success of the previous collection, Digital Technology in the Management and Prevention of Diabetes: Volume II, we are pleased to announce the ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

A large study of 133,764 adults found that a voluntary digital lifestyle program reduced 10-year diabetes risk by 45.6% in prediabetics and doubled remission rates in diabetics, with significant ...

A key program using traditional medicine and foods to tackle chronic disease in Native American and Alaska Native communities has been gutted in the federal health layoffs ...

Health and Human Services Secretary Robert F. Kennedy, Jr., spoke about food availability, but his comments on AI in health ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.

Eligible residents living with diabetes in Saskatchewan who rely on any type of insulin may be eligible to receive coverage ...